Planegg-Martinsried, Germany - Formycon AG (FSE: FYB, Prime Standard) (“Formycon” or “the Company”) today provided an update on key developments across various biosimilar projects and invites ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback